Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study

• DOI: 10.1371/journal.pone.0243604
• Publication Date: 2020-12-15T19:11:22Z
• Authors: Thiago Domingos C...; Ricardo Luiz Cord...; João Carlos Campo...; Bruno Caldin da S...; Roseny dos Reis R...; Guilherme Martins...; Thais Dias Midega; Niklas Söderberg ...; Bárbara Vieira Ca...; Flávia Nunes Dias...; Hélio Penna Guima...; Gustavo Faissol J...; Valdir Fernandes ...; Leonardo José Rol...
• Keywords: Aged, 80 and over; Male; 2. Zero hunger; Platelet Function Tests; SARS-CoV-2; Science; Fibrinolysis; Q; R; COVID-19; Middle Aged; Antithrombins; Protein S; Thrombelastography; 3. Good health; Intensive Care Units; 03 medical and health sciences; 0302 clinical medicine; Medicine; Humans; Female; Blood Coagulation Tests; Research Article; Aged; Protein C

Background Coagulation abnormalities in COVID-19 patients have not been addressed in depth.

Objective To perform a longitudinal evaluation of coagulation profile of patients admitted to the ICU with COVID-19.

Methods Conventional coagulation tests, rotational thromboelastometry (ROTEM), platelet function, fibrinolysis, antithrombin, protein C and S were measured at days 0, 1, 3, 7 and 14. Based on median total maximum SOFA score, patients were divided in two groups: SOFA ≤ 10 and SOFA > 10.

Results Thirty patients were studied. Some conventional coagulation tests, as aPTT, PT and INR remained unchanged during the study period, while alterations on others coagulation laboratory tests were detected. Fibrinogen levels were increased in both groups. ROTEM maximum clot firmness increased in both groups from Day 0 to Day 14. Moreover, ROTEM–FIBTEM maximum clot firmness was high in both groups, with a slight decrease from day 0 to day 14 in group SOFA ≤ 10 and a slight increase during the same period in group SOFA > 10. Fibrinolysis was low and decreased over time in all groups, with the most pronounced decrease observed in INTEM maximum lysis in group SOFA > 10. Also, D-dimer plasma levels were higher than normal reference range in both groups and free protein S plasma levels were low in both groups at baseline and increased over time, Finally, patients in group SOFA > 10 had lower plasminogen levels and Protein C ​​than patients with SOFA <10, which may represent less fibrinolysis activity during a state of hypercoagulability.

Conclusion COVID-19 patients have a pronounced hypercoagulability state, characterized by impaired endogenous anticoagulation and decreased fibrinolysis. The magnitude of coagulation abnormalities seems to correlate with the severity of organ dysfunction. The hypercoagulability state of COVID-19 patients was not only detected by ROTEM but it much more complex, where changes were observed on the fibrinolytic and endogenous anticoagulation system.